Ocular Therapeutix, Inc. (OCUL) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$9.77
Day's range
$10.25

Ocular Therapeutix Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
FMR LLC 05/15/2026 32.65 M $276.58 M   2.73% 17.44%
DEEP TRACK CAPITAL, LP 05/15/2026 19.69 M $166.74 M   143.93% 10.51%
BLACKROCK, INC. 05/13/2026 16.13 M $136.65 M   3.40% 8.62%
AVORO CAPITAL ADVISORS LLC 05/15/2026 12.32 M $104.31 M   14.26% 6.58%
SUMMER ROAD LLC 04/23/2026 11.88 M $100.62 M   6.94% 6.34%
VR ADVISER, LLC 05/15/2026 10.35 M $87.64 M   41.44% 5.53%
05/15/2026 8.72 M $73.85 M   100.00% 4.66%
PRICE T ROWE ASSOCIATES INC /MD/ 05/15/2026 5.90 M $49.95 M   3,338.09% 3.15%
POINT72 ASSET MANAGEMENT, L.P. 05/15/2026 5.53 M $46.88 M   444.65% 2.96%
STATE STREET CORP 05/15/2026 4.71 M $39.88 M   12.20% 2.51%
GEODE CAPITAL MANAGEMENT, LLC 05/15/2026 4.53 M $38.37 M   3.96% 2.42%
ALLIANCEBERNSTEIN L.P. 05/15/2026 4.13 M $50.13 M   -4.89% 2.21%
LOGOS GLOBAL MANAGEMENT LP 05/15/2026 3.85 M $32.61 M   10.00% 2.06%
OCTAGON CAPITAL ADVISORS LP 05/15/2026 3.17 M $26.82 M   20.70% 1.69%
BALYASNY ASSET MANAGEMENT L.P. 05/15/2026 2.69 M $22.81 M   252.64% 1.44%
COMMODORE CAPITAL LP 05/15/2026 2.58 M $21.81 M   100.00% 1.38%
DELTEC ASSET MANAGEMENT LLC 04/24/2026 2.34 M $19.83 M   -5.92% 1.25%
TWO SIGMA INVESTMENTS, LP 05/15/2026 1.83 M $15.50 M   380.72% 0.98%
WOODLINE PARTNERS LP 05/15/2026 1.67 M $14.12 M   0.09% 0.89%
TCG CROSSOVER MANAGEMENT, LLC 05/15/2026 1.65 M $13.96 M   -71.29% 0.88%
05/08/2026 1.59 M $13.51 M   100.00% 0.85%
INVESCO LTD. 05/12/2026 1.54 M $13.02 M   71.58% 0.82%
NORTHERN TRUST CORP 05/14/2026 1.53 M $12.92 M   4.32% 0.81%
UBS GROUP AG 05/05/2026 1.52 M $12.88 M   22.14% 0.81%
06/12/2026 1.49 M $12.60 M   118.24% 0.79%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 05/15/2026 1.46 M $12.38 M   0.05% 0.78%
MORGAN STANLEY 05/15/2026 1.28 M $10.84 M   45.61% 0.68%
VANGUARD FIDUCIARY TRUST CO 05/08/2026 1.25 M $10.55 M   100.00% 0.66%
CAPTION MANAGEMENT, LLC 05/15/2026 1.18 M $9.96 M   5,778.50% 0.63%
RENAISSANCE TECHNOLOGIES LLC 05/14/2026 1.15 M $9.72 M   45.09% 0.61%
GOLDMAN SACHS GROUP INC 05/15/2026 1.11 M $9.40 M   -28.25% 0.59%
SQUAREPOINT OPS LLC 05/15/2026 980.76 K $8.31 M   122.68% 0.52%
SIO CAPITAL MANAGEMENT, LLC 05/14/2026 968.60 K $8.20 M   100.00% 0.52%
CANDRIAM S.C.A. 04/30/2026 949.22 K $8.04 M   12.79% 0.51%
ARTISAN PARTNERS LIMITED PARTNERSHIP 05/13/2026 902.93 K $7.65 M   -15.09% 0.48%
EMPIRE LIFE INVESTMENTS INC. 05/11/2026 884.30 K $7.37 M   63.72% 0.47%
READYSTATE ASSET MANAGEMENT LP 05/15/2026 883.62 K $7.48 M   100.00% 0.47%
RAYMOND JAMES FINANCIAL INC 05/14/2026 859.49 K $7.28 M   2.05% 0.46%
JANE STREET GROUP, LLC 05/12/2026 804.59 K $6.81 M   -22.20% 0.43%
CETERA INVESTMENT ADVISERS 05/13/2026 764.62 K $6.48 M   5.82% 0.41%
WALLEYE CAPITAL LLC 05/13/2026 741.14 K $6.28 M   221.52% 0.40%
MARSHALL WACE, LLP 05/15/2026 740.80 K $6.27 M   -46.21% 0.40%
PEREGRINE CAPITAL MANAGEMENT LLC 04/23/2026 720.46 K $6.10 M   26.15% 0.38%
HRT FINANCIAL LP 05/14/2026 709.22 K $6.01 M   76.00% 0.38%
DIMENSIONAL FUND ADVISORS LP 05/07/2026 649.76 K $5.49 M   100.00% 0.35%
CITADEL ADVISORS LLC 05/15/2026 635.92 K $5.39 M   -74.32% 0.34%
DEUTSCHE BANK AG\ 05/06/2026 631.74 K $5.35 M   6.94% 0.34%
TUDOR INVESTMENT CORP ET AL 05/15/2026 614.38 K $5.20 M   24.17% 0.33%
KNOLL CAPITAL MANAGEMENT, LLC 05/15/2026 600.40 K $5.09 M   0.00% 0.32%
OPALEYE MANAGEMENT INC. 05/15/2026 600.00 K $5.08 M   -62.38% 0.32%

Ocular Therapeutix Inc institutional Ownership - FAQ's

During the previous two years, 345 institutional investors and hedge funds held shares of Ocular Therapeutix Inc. The most heavily invested institutionals were:

FMR LLC: 32.65 M

Deep Track Capital, LP: 19.69 M

BlackRock, Inc.: 16.13 M

Avoro Capital Advisors LLC: 12.32 M

SUMMER ROAD LLC: 11.88 M

VR Adviser, LLC: 10.35 M

110.41% of Ocular Therapeutix Inc stock is owned by institutional investors.

Institutional investors have bought a total of 221.77 M shares in the last 24 months. This purchase volume represents approximately $2.20 B in transactions.